Publication | Closed Access

Metabolic tumour volume of anal carcinoma on 18FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival

Metabolic Tumour VolumeRadiation TherapyOncologic ImagingMedicinePathologyClinical Radiation OncologyOncologyNuclear MedicineAnal CarcinomaTumor MicroenvironmentCancer ResearchRadiologyRecurrence Free Survival